title: Restitution of defective glucose-stimulated insulin release of sulfonylurea type 1 receptor knockout mice by acetylcholine.
abstract: Inhibition of ATP-sensitive K+ (K(ATP)) channels by an increase in the ATP/ADP ratio and the resultant membrane depolarization are considered essential in the process leading to insulin release (IR) from pancreatic beta-cells stimulated by glucose. It is therefore surprising that mice lacking the sulfonylurea type 1 receptor (SUR1-/-) in beta-cells remain euglycemic even though the knockout is expected to cause hypoglycemia. To complicate matters, isolated islets of SUR1-/- mice secrete little insulin in response to high glucose, which extrapolates to hyperglycemia in the intact animal. It remains thus unexplained how euglycemia is maintained. In recognition of the essential role of neural and endocrine regulation of IR, we evaluated the effects of acetylcholine (ACh) and glucagon-like peptide-1 (GLP-1) on IR and free intracellular Ca2+ concentration ([Ca2+]i) of freshly isolated or cultured islets of SUR1-/- mice and B6D2F1 controls (SUR1+/+). IBMX, a phosphodiesterase inhibitor, was also used to explore cAMP-dependent signaling in IR. Most striking, and in contrast to controls, SUR1-/-) islets are hypersensitive to ACh and IBMX, as demonstrated by a marked increase of IR even in the absence of glucose. The hypersensitivity to ACh was reproduced in control islets by depolarization with the SUR1 inhibitor glyburide. Pretreatment of perifused SUR1-/- islets with ACh or IBMX restored glucose stimulation of IR, an effect expectedly insensitive to diazoxide. The calcium channel blocker verapamil reduced but did not abolish ACh-stimulated IR, supporting a role for intracellular Ca2+ stores in stimulus-secretion coupling. The effect of ACh on IR was greatly potentiated by GLP-1 (10 nM). ACh caused a dose-dependent increase in [Ca2+]i at 0.1-1 microM or biphasic changes (an initial sharp increase in [Ca2+]i followed by a sustained phase of low [Ca2+]i) at 1-100 microM. The latter effects were observed in substrate-free medium or in the presence of 16.7 mM glucose. We conclude that SUR1 deletion depolarizes the beta-cells and markedly elevates basal [Ca2+]i. Elevated [Ca2+]i in turn sensitizes the beta-cells to the secretory effects of ACh and IBMX. Priming by the combination of high [Ca2+]i, ACh, and GLP-1 restores the defective glucose responsiveness, precluding the development of diabetes but not effectively enough to cause hyperinsulinemic hypoglycemia.
authors.affiliation: Diabetes Research Center, Department of Biochemistry and Biophysics, Univ. of Pennsylvania, Philadelphia, PA 19104-6015, USA. nicolai@mail.med.upenn.edu
authors.forename: Nicolai M
authors.initials: NM
authors.lastname: Doliba
authors.forename: Wei
authors.initials: W
authors.lastname: Qin
authors.forename: Marko Z
authors.initials: MZ
authors.lastname: Vatamaniuk
authors.forename: Changhong
authors.initials: C
authors.lastname: Li
authors.forename: Dorothy
authors.initials: D
authors.lastname: Zelent
authors.forename: Habiba
authors.initials: H
authors.lastname: Najafi
authors.forename: Carol W
authors.initials: CW
authors.lastname: Buettger
authors.forename: Heather W
authors.initials: HW
authors.lastname: Collins
authors.forename: Richard D
authors.initials: RD
authors.lastname: Carr
authors.forename: Mark A
authors.initials: MA
authors.lastname: Magnuson
authors.forename: Franz M
authors.initials: FM
authors.lastname: Matschinsky
mesh_terms: D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D018528:ATP-Binding Cassette Transporters; D000109:Acetylcholine / Q000502:physiology*; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism; D005934:Glucagon / Q000502:physiology; D052216:Glucagon-Like Peptide 1; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism / Q000502:physiology*; D000078790:Insulin Secretion; D007424:Intracellular Fluid / Q000378:metabolism; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism*; D008564:Membrane Potentials / Q000502:physiology; D051379:Mice; D008815:Mice, Inbred Strains; D018345:Mice, Knockout; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000172:deficiency / Q000502:physiology*; D010446:Peptide Fragments / Q000502:physiology; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D024661:Potassium Channels, Inwardly Rectifying; D011498:Protein Precursors / Q000502:physiology; D011955:Receptors, Drug; D015290:Second Messenger Systems / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology; D064233:Sulfonylurea Receptors
chemical_list: D015056:1-Methyl-3-isobutylxanthine; D018528:ATP-Binding Cassette Transporters; D000109:Acetylcholine; D001786:Blood Glucose; D002118:Calcium; D005934:Glucagon; D052216:Glucagon-Like Peptide 1; D007328:Insulin; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D010446:Peptide Fragments; D010726:Phosphodiesterase Inhibitors; D024661:Potassium Channels, Inwardly Rectifying; D011498:Protein Precursors; D011955:Receptors, Drug; D064233:Sulfonylurea Receptors; C577508:Abcc8 protein, mouse